Reporters for the Wall Street Journal and the Financial Times almost simultaneously reported Sunday afternoon that Actavis and Allergan were getting close to a friendly acquisition deal, which the FT cited as a $64 billion deal in the making.

…read more

Source: Buzz: Actavis closes in on Big Pharma status with $64B Allergan buyout


0 No comments